ADVANCES IN THE DIAGNOSIS PATHOGENESIS AND TREATMENT OF CIDP PDF
Download Citation on ResearchGate | Advances in the diagnosis, pathogenesis and treatment of CIDP | Chronic inflammatory demyelinating. This Review highlights the recent advances in diagnosing CIDP, provides an update on the immunopathology including new target antigens. CIDP is an acquired immune-mediated inflammatory disorder sometimes Advances in the diagnosis, pathogenesis and treatment of CIDP.
|Published (Last):||9 August 2013|
|PDF File Size:||15.84 Mb|
|ePub File Size:||6.97 Mb|
|Price:||Free* [*Free Regsitration Required]|
Advances in the diagnosis, pathogenesis and treatment of CIDP
Skip to search form Skip to main content. Despite clinical challenges in diagnosis—owing in part to the existence of disease variants, and different views on how many electrophysiological abnormalities are needed to document demyelination—consensus criteria seem to have been reached for research or clinical practice.
This paper has been referenced on Twitter 1 time over the past 90 days. From This Paper Figures, tables, and topics from this paper.
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Search for additional papers on this topic. Topics Discussed in This Paper. Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Immunoglobulins, Intravenous Demyelinating peripheral neuropathy Polyneuropathy. Citations Publications citing this paper. Showing of 60 extracted citations. Evidence from Human and Animal Studies: An update on the management of chronic inflammatory demyelinating polyneuropathy. Kenneth Craig Gorson Therapeutic advances in neurological disorders Diagnostic insights into chronic-inflammatory demyelinating polyneuropathies.
Subcutaneous IgG for chronic inflammatory demyelinating polyneuropathy Marinos C. Dalakas The Trestment Neurology References Publications referenced by this paper.
Showing of references.
Pathogenesis and treatment of CNS lupus. Antonis FanouriakisDimitrios T.
BoumpasGeorge K. Bertsias Current opinion in rheumatology An open label clinical trial of complement inhibition in multifocal motor neuropathy. John Diagnosi PollardPatricia J.